http://livercancer.stanford.edu/media/SFChronicle01-03-03.pdf Liver cancer kills more people in the Bay Area than anywhere
in the country, according to the Centers for Disease Control and Prevention
-- and by a wide margin.
The Asian Liver Center at Stanford University estimates that 10 percent
of Asian Americans have hepatitis B and don't know it.
If these ominous statistics are true, we're facing the biggest health
crisis to hit the region since AIDS.
That epidemic took 19,000 lives in San Francisco in its first 20 years,
as counted by the San Francisco Department of Public Health.
Few are talking about hepatitis B in Asian Americans, however, because
this is a silent epidemic.
hep C
http://www.southalabama.edu/nursing/herreranotes/hep
C.PDF A. RNA virus, the least infectious of the hepatitis viruses,
but more infectious than HIV B. Exists as various genotypes (or strains)
determined by genomic sequence 1.
3. Factors independently associated with risk of infection a.
4. Risk not associated with health-related occupation a.
rarely needed nowadays in clinical practice c. a positive anti-HCV no
longer needs to be confirmed by RIBA 3.
A. Hepatitis C is a progressive disease leading to fibrosis 1.
4. factors that are likely to accelerate progression to cirrhosis a.
Most useful test to establish severity of disease and determine prognosis
1.
5. Centers for Disease Control and Prevention.
dsp_42024
Inclusion of the Armored RNA Hepatitis G Virus preparation
into a commercial product requires a license from Ambion, Inc. Catalog
number:
Suggested use of Armored RNA Hepatitis G Virus for gel detection assays
For each positive control, 5 µL of Armored RNA Hepatitis G Virus
is required per RT-PCR reaction.
5 µL of Armored RNA Hepatitis G Virus as template and the Schlueter,
1996 primer set in a 50 µL RT-PCR reaction will yield a strongly
visible band of 185 basepairs upon fractionation in an agarose gel with
ethidium bromide staining.
Armored RNA® technology is a system for producing robust, ribonuclease-resistant
RNA controls and standards by assembling specific RNA sequences and viral
coat proteins into pseudo-viral particles (DuBois, 1999).
bbp_surv
I understand that due to my occupational exposure to blood
or other potentially infectious materials I may be at risk of acquiring
hepatitis B virus (HBV) infection.
I have been given the opportunity to be vaccinated with hepatitis B vaccine,
at no charge to myself.
I understand that by declining this vaccine, I continue to be at risk
of acquiring hepatitis B, a serious disease.
If in the future I continue to have occupational exposure to blood or
other potentially infectious materials and I want to be vaccinated with
hepatitis B vaccine, I can receive the vaccination series at no charge
to me.
d03136
http://www.gao.gov/new.items/d03136.pdf In 1998, the Department of Veterans Affairs (VA) launched an
initiative to screen and test veterans for hepatitis C---a chronic blood-borne
virus that can cause potentially fatal liver-related conditions.
GAO surveyed 141 VA medical facilities about their processes for notifying
veterans concerning hepatitis C test results and evaluating veterans'
medical conditions regarding potential treatment options.
There is considerable variation among VA facilities in the time it takes
to notify veterans that they have hepatitis C. Systemwide, 71 facilities,
in response to our survey, estimated typical notification time frames
of 30 days or less, including 29 facilities with estimates of 7 days or
less.
2001TapeForm
http://www.hepcglobal.org/image
folder/2001TapeForm.pdf Hepatitis C -- A Global Perspective; Hepatitis C and the Emergency
Responder; Street Youth & Injection Drug Use: Predictors of Initiation
into Injection; Federal Health Policy and Hepatitis --an Update from Washington
DC; HIV & Hepatitis C Prevention.
Corrections & Hepatitis C Track: FACING HEPATITIS C WITHIN A CORRECTIONAL
SETTING -- Brenda Goldhammer, Katie Kramer, Phyllis Beck, Hurley Merical
#105.
Research Track: HCV RISKS IN NON-INJECTING POPULATIONS -- Dr. Nancy Moss,
Thomas Aragon, Gwen Hammer, Juan Ruiz #200.
Hepatitis C Treatment Track - Linden Young, THE NEW HCV TREATMENTS: Natalie
H. Bzowej, MD, PhD, TREATING THE SIDE-EFFECTS of THERAPY: Marion Peters,
MD #217.
MM4328
http://www.aegis.com/files/mmwr/1994/MM4328.pdf This report presents preliminary findings of an evaluation
of transmission of hepatitis C virus (HCV) infection from these products
and guidelines for monitoring patients who may have received them.
The median age of persons with reported cases was 37 years (range: 2--84
years); 52% were female, and 63% received IGIV for treatment of a primary
immuno*Use of trade names and commercial sources is for identification
only and does not imply endorsement by the Public Health Service or the
U.S. Department of Health and Human Services.
The findings in this report indicate that the proportion of persons taking
action to control their blood pressure is lower than the national health
objective.
London
http://www.fccc.edu/docs/sci_report2001 Our research is concerned with identifying and quantitating
specific environmental, viral, and genetic factors that affect the risk
of hepatocellular carcinoma (HCC) and learning how such factors influence
risk.
One study was in Haimen City, Jiangsu Province, People's Republic of China,
and the other in Senegal, West Africa.
Chronic infection with hepatitis B virus (HBV) is the major causative
factor of HCC in these populations, but other largely unknown factors
influence the occurrence of this cancer.
In our research, history of acute hepatitis, family history of liver cancer
and occupation (farmer) have been the main additional risk factors identified.
Cancer Mortality in China, Haimen City, and the United States.
bbp-appendix6
Please bring this booklet to your scheduled Hepatitis B Vaccination
appointment and present to your physician.
Recognizing the risk, the Occupational Safety and Health Administration
(OSHA) developed a safety regulation designed to prevent exposure and
protect workers from bloodborne pathogens.
This section applies to all occupational exposure to blood or other potentially
infectious materials as defined by paragraph (b) of this section.
Exposure Incident means a specific eye, mouth, other mucous membrane,
non-intact skin, or parenteral contact with blood or other potentially
infectious materials that results from the performance of an employee's
duties.
Reusable sharps that are contaminated with blood or other potentially
infectious materials shall not be stored or processed in a manner that
requires employees to reach by hand into the containers where these sharps
have been placed.
Salomon_HepCModel_AmJEpi2002
Model predictions produced by each set of sampled values were
compared with available epidemiologic data on infection prevalence and
mortality from liver cancer, and various goodness-of-fit criteria were
used to identify the range of parameter values that were consistent with
these data.
Hepatitis C virus (HCV) is the most common blood-borne infection in the
United States and is a leading cause of chronic hepatitis, cirrhosis,
and hepatocellular carcinoma (HCC) (1).
Data from the Third National Health and Nutrition Examination Survey (NHANES
III), conducted from 1988 to 1994, included serologic examinations for
markers of HCV and HBV infection in approximately 20,000 persons (81).
hepa00
http://www.lapublichealth.org/acd/reports/annual/cd00/hepa00.pdf Hepatitis A virus (HAV), a RNA-virus of the Picornaviridae
family, is a vaccine-preventable disease usually transmitted by fecal-oral
route, person-to-person, or through vehicles such as food.
Seasonality: The increase in HAV cases historically observed in summer
to early autumn and decrease in winter was observed again in 2000 (Figure
36).
The highest 2000 rate, as in prior years, was among Hispanics (9.6 per
100,000), followed by Whites (7.4).
Since HAV vaccination has become available and in more routine use, it
has been suggested that outbreaks of HAV should be effectively interrupted
through vaccine use, leading to a sustained reduction in disease incidence.
depli2000hepatitisB
http://www.santepub-mtl.qc.ca/Mi/vaccination/pdf/depli2000hepatitisB.pdf For children who have finished grade 4 and who want to be vaccinated
against hepatitis B, please inquire at the local community service centre
(CLSC) or your doctor's office.
The hepatitis B virus is usually transmitted by ual relations with
an infected person or between drug users when they share syringes or any
other injection equipment.
The hepatitis B vaccine is safe and very effective.
If your child has a serious illness that affects his or her immune system
(e.g.: leukemia), you must advise the CLSC nurse before the vaccination
so that the dose can be adjusted to the child's needs.
RogerMason
http://www.purestcolloids.com/misc/RogerMason.pdf We just don't know the actual statistics in most countries,
but we can estimate the minimum infection rate.
At least ten per cent of male homouals are infected.
It is also estimated that China's one billion plus population has at least
10 per cent of them infected with some type of hepatitis.
This is a viral inflammation of the liver and it's transferred by blood
contact.
The liver breaks down fats, processes proteins and metabolizes drugs.
Tribulus and other supplements are useless frauds.
Fortunately the prescription thyroid hormones are bioidentical and have
no side effects when used in the proper amounts.
regInfo30
This information sheet is designed to pro v i d e e m p l o
y e rs and employees with information about hepatitis B, hepatitis C and
HIV/AIDS in the workplace.
Hepatitis B, hepatitis C and HIV/AIDS are infectious diseases that are
transmitted from person to person via blood and body fluids.
However, some people are at risk because their work involves exposure
to blood and body fluids.
This especially includes health care workers and people who have contact
with used drug injecting needles.
At about six months after infection people may develop symptoms ranging
from mild to severe flu-like illness.
